Morphine sulfate
NDC 71335-0676, morphine sulfate, tablet, film coated, extended release, from Bryant Ranch Prepack.
- Product NDC
- 71335-0676
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078761
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MORPHINE SULFATE30 mg/1
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-0676-0 | 71335067600 | 40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-0) |
| 71335-0676-1 | 71335067601 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-1) |
| 71335-0676-2 | 71335067602 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-2) |
| 71335-0676-3 | 71335067603 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-3) |
| 71335-0676-4 | 71335067604 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-4) |
| 71335-0676-5 | 71335067605 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-5) |
| 71335-0676-6 | 71335067606 | 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-6) |
| 71335-0676-7 | 71335067607 | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-7) |
| 71335-0676-8 | 71335067608 | 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-8) |
| 71335-0676-9 | 71335067609 | 26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ad08cd86-3825-4e77-bbe8-f6333a9ca9d7
Use it
Look up 71335-0676 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-0676. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.